Transaction in Own Shares • Jul 11, 2022
Transaction in Own Shares
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 0431S
Intl. Biotechnology Trust PLC
11 July 2022
The Company incorrectly announced on 7 July 2022 (RNS No 7600R) that following a market purchase of 7,200 of its own Ordinary shares of 25p each, it held 520,608 Ordinary shares in treasury. The correct number of shares held in treasury is 520,808.
All other details remain unchanged.
The full amended text is shown below.
11th July 2022
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
("IBT" or the "Company")
Correction: Transaction in own shares
The Company announces that on 7th July 2022 it made a market purchase of 7,200 of its own Ordinary shares of 25p each, representing 0.02% of the issued share capital (excluding treasury shares). The shares were bought at 692.22292p per share and the Company intends to hold these shares in treasury.
As a result of the above transaction the Ordinary shares in issue, shares held in treasury, and the Total Voting Rights of the Company are now as follows:
| Number of Ordinary Shares in issue | 41,383,817 |
| Number of Ordinary Shares held in treasury | 520,808 |
| Number of Ordinary Shares in issue (excluding treasury shares) | 40,863,009 |
For further information contact:
Company Secretary - Link Company Matters
Indu Shastri +44 (0)7936 045789
LEI: 213800N1QUJ744P76D11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSGPUMGMUPPGPG
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.